Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Sun Pharmaceutical Industries Limited
Sun Pharma makes and sells generic and branded medicines and pharmaceutical ingredients to patients around the world.
Sun Pharma is one of India's largest drugmakers, and its business is simple to describe even if the science behind it is not: it makes medicines and sells them to people in more than 100 countries. Most of what it sells are generics — copies of drugs whose original patents have expired. A generic pill has the same active ingredient as the brand-name version and works the same way, but it usually costs far less. That is the core of Sun's business: high-volume, low-price medicine that pharmacies, hospitals, and governments buy because it works and it is cheap.
The company also makes something less visible: active pharmaceutical ingredients, or APIs. These are the raw chemical components that give a pill its power, and drugmakers buy them from companies like Sun to put into their own finished products. On top of that, Sun sells its own branded medicines, especially in India, where doctors prescribe products by name and trust the brand. India is a huge and growing market for the company, and it sells a wide range of treatments there — from everyday antibiotics to complex specialty drugs for cancer and skin conditions. Its biggest and most famous bet was buying Ranbaxy in 2014, a deal that turned Sun into a global generics giant but also dragged it through years of regulatory trouble, including factory problems in India that the U.S. FDA flagged and fixed. That episode is a useful reminder of what actually matters in this business: regulators, not customers, decide whether you can sell. A single failed factory inspection can freeze production and revenue overnight.
Today Sun invests heavily in specialty medicines — more complex, higher-margin drugs that are harder to copy and face less price pressure than plain generics. It also spends on research and development, pays dividends, and has kept buying smaller companies to widen its reach. The company is headquartered in Mumbai, and its shares trade on India's National Stock Exchange. In short: Sun Pharma sells the pills that keep people well, and it makes its money by being a reliable, low-cost supplier at enormous scale.
Saved answer · last researched 12 Nov 2026